MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
(loss) income
-$722,218K
(-297309.05%↓ Y/Y)
Net (loss) income
-$721,812K
(-2255762.50%↓ Y/Y)
Total other
comprehensive (loss) income
-$406K
(loss) income before
income taxes
-$720,808K
(-95193.40%↓ Y/Y)
Income tax expense
$1,004K
(38.29%↑ Y/Y)
Unrealized gain on
available for sale...
-$344K
(-121.94%↓ Y/Y)
Foreign currency
translation adjustment
-$62K
(-116.94%↓ Y/Y)
Product
$151,401K
(5.30%↑ Y/Y)
License And Other
Revenues
$5,012K
(loss) income from
operations
-$701,598K
(-3405.22%↓ Y/Y)
Total other expense,
net
-$19,210K
(6.15%↑ Y/Y)
Total revenues
$156,413K
(7.48%↑ Y/Y)
Interest income
$2,256K
(-25.40%↓ Y/Y)
Total operating
expenses
$858,011K
(590.24%↑ Y/Y)
Interest expense
$19,779K
(-15.81%↓ Y/Y)
Other expense, net
-$1,462K
Foreign currency
(losses) gains, net
-$225K
(-22600.00%↓ Y/Y)
Acquired in-process
research and development
$697,761K
Selling, general and
administrative
$94,554K
(14.65%↑ Y/Y)
Research and development
$60,319K
(61.84%↑ Y/Y)
Cost of product sales
$5,377K
(17.71%↑ Y/Y)
Back
Back
Income Statement
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)
source: myfinsight.com